- Previous Close
383.24 - Open
381.24 - Bid 385.46 x 800
- Ask 385.76 x 800
- Day's Range
380.52 - 390.80 - 52 Week Range
362.21 - 567.26 - Volume
682,875 - Avg. Volume
1,993,496 - Market Cap (intraday)
89.483B - Beta (5Y Monthly) 0.85
- PE Ratio (TTM)
14.04 - EPS (TTM)
27.48 - Earnings Date Jan 23, 2025
- Forward Dividend & Yield 6.52 (1.70%)
- Ex-Dividend Date Dec 5, 2024
- 1y Target Est
500.87
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits. The company operates in the pharmacy services business; and markets and offers pharmacy services, including pharmacy benefit management, as well as home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services. In addition, it provides healthcare-related services and capabilities, including utilization management, behavioral health, integrated care delivery, palliative care, payment integrity services, subrogation services, and health and wellness programs, as well as services related to data management, information technology, and business operations. Further, the company is involved in the National Government Services business. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brand names. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is headquartered in Indianapolis, Indiana.
www.elevancehealth.com104,900
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: ELV
View MorePerformance Overview: ELV
Trailing total returns as of 1/10/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ELV
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ELV
View MoreValuation Measures
Market Cap
88.88B
Enterprise Value
108.16B
Trailing P/E
13.95
Forward P/E
10.98
PEG Ratio (5yr expected)
0.71
Price/Sales (ttm)
0.52
Price/Book (mrq)
2.03
Enterprise Value/Revenue
0.62
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
3.69%
Return on Assets (ttm)
5.84%
Return on Equity (ttm)
15.50%
Revenue (ttm)
174.02B
Net Income Avi to Common (ttm)
6.42B
Diluted EPS (ttm)
27.48
Balance Sheet and Cash Flow
Total Cash (mrq)
37.93B
Total Debt/Equity (mrq)
61.87%
Levered Free Cash Flow (ttm)
-1.11B